Supplement Claim Guidance Stresses Human Studies, But Leaves Questions
This article was originally published in The Tan Sheet
Executive Summary
An FDA guidance could leave dietary supplement firms confused on what is appropriate evidence for substantiating structure/function claims
You may also be interested in...
Align Supplement Industry Regulation With DSHEA, Groups Tell FDA In 'Responsible Innovation' Comments
Targeted guidance on questions around NDINs and using import alerts to keep violative products off market are among supplement industry trade groups' suggestions for improving FDA oversight of the industry. Groups also continue asserting that the agency can strengthen its VMS product manufacturing and marketing oversight with its existing authorities.
Qualifying Language For Supplement Claims Needs Clarification – CRN
The role that qualifying language can play in dietary supplement structure/function claims is unclear in FDA's draft guidance on claim substantiation, the Council for Responsible Nutrition says in Jan. 10 comments
Supplement Substantiation Claims Guidance Aims For Clarity
FDA expects a new guidance detailing the boundaries of "competent and reliable scientific information" will enhance consumer confidence in supplement claims